Page last updated: 2024-08-17

medroxyprogesterone acetate and Carcinoma, Hepatocellular

medroxyprogesterone acetate has been researched along with Carcinoma, Hepatocellular in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (60.00)18.2507
2000's1 (20.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chang, CW; Wang, SN; Wei, RJ; Yeh, YT1
Chai, CY; Lee, KT; Wang, SN; Yang, SF; Yeh, YT1
Gondo, H; Nakajima, Y; Sato, N; Sato, Y; Uchino, J; Une, Y1
Coe, JE; Ishak, KG; Ross, MJ1
Kamiyama, T; Kawamukai, Y; Nagabuchi, E; Nakajima, Y; Ogasawara, K; Sato, N; Sato, Y; Uchino, J; Une, Y1

Reviews

1 review(s) available for medroxyprogesterone acetate and Carcinoma, Hepatocellular

ArticleYear
Progesterone and related compounds in hepatocellular carcinoma: basic and clinical aspects.
    BioMed research international, 2013, Volume: 2013

    Topics: Androgens; Antineoplastic Agents, Hormonal; Carcinoma, Hepatocellular; Estrogens; Female; Humans; Liver Neoplasms; Male; Medroxyprogesterone Acetate; Megestrol Acetate; Sex Characteristics

2013

Trials

1 trial(s) available for medroxyprogesterone acetate and Carcinoma, Hepatocellular

ArticleYear
Chemohormonal therapy of unresectable hepatocellular carcinoma.
    American journal of clinical oncology, 1993, Volume: 16, Issue:3

    Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemical and Drug Induced Liver Injury; Cisplatin; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Kidney Diseases; Leukopenia; Liver Diseases; Liver Neoplasms; Male; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Staging; Prospective Studies; Remission Induction; Survival Rate; Tamoxifen

1993

Other Studies

3 other study(ies) available for medroxyprogesterone acetate and Carcinoma, Hepatocellular

ArticleYear
Potential role of leptin expression in hepatocellular carcinoma.
    Journal of clinical pathology, 2006, Volume: 59, Issue:9

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Carcinoma, Hepatocellular; Disease Progression; Female; Follow-Up Studies; Humans; Immunoenzyme Techniques; Ki-67 Antigen; Leptin; Liver Neoplasms; Male; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Proteins; Neovascularization, Pathologic; Platelet Endothelial Cell Adhesion Molecule-1; Prognosis; Survival Analysis; Treatment Outcome

2006
Estrogen-induced hepatic toxicity and hepatic cancer: differences between two closely related hamster species.
    Liver, 1998, Volume: 18, Issue:5

    Topics: Adenoma, Liver Cell; Animals; Bilirubin; Carcinoma, Hepatocellular; Cricetinae; Cricetulus; Diethylstilbestrol; Estrogens; Female; Inclusion Bodies; Liver; Liver Neoplasms, Experimental; Male; Medroxyprogesterone Acetate; Mifepristone; Species Specificity; Tamoxifen; Zeranol

1998
[A case of double cancer of gastric and hepatocellular carcinoma associated with cirrhosis treated by hepatic resection after intra-hepatic arterial infusion chemotherapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1990, Volume: 17, Issue:8 Pt 2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; Combined Modality Therapy; Doxorubicin; Gastrectomy; Hepatectomy; Hepatic Artery; Humans; Infusions, Intra-Arterial; Iodized Oil; Liver Cirrhosis; Liver Neoplasms; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasms, Multiple Primary; Stomach Neoplasms; Tamoxifen

1990